new YORK (Reuters Health) – according to a new study,

colon cancer patients under 50 years of age and those of

low income or unemployed were more likely to experience

severe financial as a result of treatment problems

to save their lives.

The residents of the State of Washington to study

were under treatment for colon cancer found that compared

with seniors, 50 children had more than 50 times

more possibility you need to sell or refinance their homes,

lose 20 percent or more of the wage, borrow or request a

loan to friends and family.

Patients with incomes below $ 30,000

annual were eight times more likely to have these problems

economic than those with higher incomes.

“Most oncologists know these stories of

“”

patients that spend lots of money on their treatment”, said the

Dr. Veena Shankaran, author of the study and oncologist

of University of Washington. “They are stories that always

we hear in clinics and wanted to know its extent”,

added.

The authors found that the majority of patients

they do not talk with doctors about the cost of treatments

and some saltearon up or rejected therapies for the price.

Shankaran team performed a survey of 555

residents in several areas of the State of Washington with cancer

advanced colon diagnosed between 2008 and 2010. Of the

284 responded, 104 had at least one problem

economic associated with treatment.

“We were surprised to find almost 40 percent of the

“”

patients with these changes”, said author.

The hypothesis of the authors was that these groups had less

savings and other resources that support when they began

to accumulate the copayments and refused refunds.

Another 27 percent of the participants mentioned effects

economic not so serious, including the sale of shares, the use

savings or retirement account, or a reduction of the

less than 20 percent income.

The team also identified that a 5 per cent had

sautéed treatment because of its cost and that 7 percent as

had rejected for the same reason.

In an editorial published in Journal of Clinical Oncology,

researcher Cathy Bradley, of the Faculty of Medicine of

Virginia Commonwealth University, Richmond, wrote that the

health system can avoid these economic collapses to

cause cancer treatments.

Points out that a long-term strategy would be to invest

in prevention. For example: Medicare should be able to negotiate the

cancer drugs costs or cover the alternative more

economic if it is demonstrated that the result is the same.

In addition, said doctors should talk with their

patients on the costs and how much it should pay.

“Must understand how much will cost them to them and their

families. “Need to make informed decisions”, said Bradley

to Reuters Health.

In its editorial, Bradley explains that eight weeks of

chemotherapy can exceed $30,000. The team of

Shankaran found that only 42 per cent of patients

remembered having conversed with their doctors about the costs.

For Bradley “is a problem of policies and patients

trapped in the middle (…) “There is not much that they can

do to resolve it”.

Shankaran commented that most oncologists have with

a financial adviser available to patients and

there are also online resources.

Source: Journal of Clinical Oncology, online March 12,

2012.